PTGS2 and lung carcinoma: According to Cornett and Lutz [58], the introduction of miR-146a can specifically ablate Cox-2 protein and the biological activity of Cox-2, they proposed that decreased miR-146a expression contributes to the up-regulation and overexpression of Cox-2 in lung cancer cells [58].